News
The global Alagille syndrome market is experiencing significant growth driven by rising awareness, advancements in diagnostic tools, and increased adoption of genetic testing. The market's expansion ...
8h
Zacks.com on MSNEMA Accepts GSK's Filing for Linerixibat in Rare Disease-Related ItchGSK plc GSK announced that the European Medicines Agency has accepted its marketing authorization application (MAA) seeking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results